
James William Rogers
Examiner (ID: 18141, Phone: (571)272-7838 , Office: P/1618 )
| Most Active Art Unit | 1618 |
| Art Unit(s) | 1618 |
| Total Applications | 1196 |
| Issued Applications | 505 |
| Pending Applications | 144 |
| Abandoned Applications | 587 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18496232
[patent_doc_number] => 20230218799
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => BIOCOMPATIBLE HYDROGEL TREATMENTS FOR RETINAL DETACHMENT
[patent_app_type] => utility
[patent_app_number] => 18/152430
[patent_app_country] => US
[patent_app_date] => 2023-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27668
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18152430
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/152430 | BIOCOMPATIBLE HYDROGEL TREATMENTS FOR RETINAL DETACHMENT | Jan 9, 2023 | Pending |
Array
(
[id] => 18418412
[patent_doc_number] => 20230172870
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => SURFACE CONJUGATION TO POLY(AMINE-CO-ESTER) NANOPARTICLES FOR TARGETING TO CELLS AND TISSUES
[patent_app_type] => utility
[patent_app_number] => 18/063613
[patent_app_country] => US
[patent_app_date] => 2022-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13357
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18063613
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/063613 | SURFACE CONJUGATION TO POLY(AMINE-CO-ESTER) NANOPARTICLES FOR TARGETING TO CELLS AND TISSUES | Dec 7, 2022 | Abandoned |
Array
(
[id] => 18363214
[patent_doc_number] => 20230144805
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => Methods of Noninvasive Detection and Specific Treatment for Cancer Metastasis
[patent_app_type] => utility
[patent_app_number] => 18/054149
[patent_app_country] => US
[patent_app_date] => 2022-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1641
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18054149
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/054149 | Methods of Noninvasive Detection and Specific Treatment for Cancer Metastasis | Nov 9, 2022 | Pending |
Array
(
[id] => 18221385
[patent_doc_number] => 20230060379
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => FULLERENE AND ITS USE TO MAINTAIN GOOD HEALTH AND TO PROLONG THE EXPECTED LIFESPAN OF MAMMALS
[patent_app_type] => utility
[patent_app_number] => 18/047181
[patent_app_country] => US
[patent_app_date] => 2022-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5885
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18047181
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/047181 | FULLERENE AND ITS USE TO MAINTAIN GOOD HEALTH AND TO PROLONG THE EXPECTED LIFESPAN OF MAMMALS | Oct 16, 2022 | Pending |
Array
(
[id] => 18932288
[patent_doc_number] => 11884695
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-30
[patent_title] => Heavy vitamin B12 derivatives
[patent_app_type] => utility
[patent_app_number] => 18/045596
[patent_app_country] => US
[patent_app_date] => 2022-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5847
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18045596
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/045596 | Heavy vitamin B12 derivatives | Oct 10, 2022 | Issued |
Array
(
[id] => 18784839
[patent_doc_number] => 20230372499
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-23
[patent_title] => DENDRIMER COMPOSITIONS AND METHODS FOR DRUG DELIVERY
[patent_app_type] => utility
[patent_app_number] => 17/962297
[patent_app_country] => US
[patent_app_date] => 2022-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30292
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17962297
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/962297 | DENDRIMER COMPOSITIONS AND METHODS FOR DRUG DELIVERY | Oct 6, 2022 | Abandoned |
Array
(
[id] => 18222980
[patent_doc_number] => 20230061974
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => POLY (BETA-AMINO ESTERS) AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/939528
[patent_app_country] => US
[patent_app_date] => 2022-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25460
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17939528
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/939528 | Poly(beta-amino esters) and uses thereof | Sep 6, 2022 | Issued |
Array
(
[id] => 18322903
[patent_doc_number] => 20230121031
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => MASKED FLUOROGENIC COMPOUNDS AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/898995
[patent_app_country] => US
[patent_app_date] => 2022-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17589
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 335
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17898995
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/898995 | MASKED FLUOROGENIC COMPOUNDS AND METHODS OF USING THE SAME | Aug 29, 2022 | Pending |
Array
(
[id] => 18285365
[patent_doc_number] => 20230100837
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => NANOPARTICLE COMPOSITIONS CONTAINING SUGAR FUNCTIONALIZED NUCLEIC ACID CARRIERS
[patent_app_type] => utility
[patent_app_number] => 17/885974
[patent_app_country] => US
[patent_app_date] => 2022-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13861
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17885974
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/885974 | Nanoparticle compositions containing sugar functionalized nucleic acid carriers | Aug 10, 2022 | Issued |
Array
(
[id] => 18019123
[patent_doc_number] => 20220370622
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY
[patent_app_type] => utility
[patent_app_number] => 17/879441
[patent_app_country] => US
[patent_app_date] => 2022-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28921
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17879441
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/879441 | Pharmaceutical compositions and related methods of delivery | Aug 1, 2022 | Issued |
Array
(
[id] => 18019122
[patent_doc_number] => 20220370621
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY
[patent_app_type] => utility
[patent_app_number] => 17/879430
[patent_app_country] => US
[patent_app_date] => 2022-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28920
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17879430
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/879430 | Pharmaceutical compositions and related methods of delivery | Aug 1, 2022 | Issued |
Array
(
[id] => 19441245
[patent_doc_number] => 12091486
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-17
[patent_title] => Block copolymer and micelle compositions and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 17/810591
[patent_app_country] => US
[patent_app_date] => 2022-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 21
[patent_no_of_words] => 17374
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17810591
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/810591 | Block copolymer and micelle compositions and methods of use thereof | Jun 30, 2022 | Issued |
Array
(
[id] => 19396182
[patent_doc_number] => 12070511
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-27
[patent_title] => Lanthanide complex formulations
[patent_app_type] => utility
[patent_app_number] => 17/851454
[patent_app_country] => US
[patent_app_date] => 2022-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8534
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 263
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17851454
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/851454 | Lanthanide complex formulations | Jun 27, 2022 | Issued |
Array
(
[id] => 17895464
[patent_doc_number] => 20220305126
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => METHOD FOR REMOVING ACETALDEHYDE
[patent_app_type] => utility
[patent_app_number] => 17/838638
[patent_app_country] => US
[patent_app_date] => 2022-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2330
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17838638
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/838638 | Method for removing acetaldehyde | Jun 12, 2022 | Issued |
Array
(
[id] => 19135573
[patent_doc_number] => 11970503
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-30
[patent_title] => Radiopharmaceuticals, radioimaging agents, and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/834773
[patent_app_country] => US
[patent_app_date] => 2022-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 11
[patent_no_of_words] => 9835
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17834773
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/834773 | Radiopharmaceuticals, radioimaging agents, and uses thereof | Jun 6, 2022 | Issued |
Array
(
[id] => 18075980
[patent_doc_number] => 20220401592
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => LOW MOLECULAR WEIGHT AND POLYAMIDOAMINE (PAMAM) DENDRIMER BASED PSMA-SPECIFIC DUAL CONTRAST AGENTS FOR OPTICAL AND PHOTOACOUSTIC IMAGING AND THERANOSTIC AGENTS FOR TREATING PROSTATE CANCER
[patent_app_type] => utility
[patent_app_number] => 17/744080
[patent_app_country] => US
[patent_app_date] => 2022-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21677
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17744080
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/744080 | LOW MOLECULAR WEIGHT AND POLYAMIDOAMINE (PAMAM) DENDRIMER BASED PSMA-SPECIFIC DUAL CONTRAST AGENTS FOR OPTICAL AND PHOTOACOUSTIC IMAGING AND THERANOSTIC AGENTS FOR TREATING PROSTATE CANCER | May 12, 2022 | Pending |
Array
(
[id] => 17865509
[patent_doc_number] => 20220288244
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-15
[patent_title] => COMBINATION RADIOIMMUNOTHERAPY AND CD47 BLOCKADE IN THE TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 17/726296
[patent_app_country] => US
[patent_app_date] => 2022-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26593
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 433
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17726296
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/726296 | COMBINATION RADIOIMMUNOTHERAPY AND CD47 BLOCKADE IN THE TREATMENT OF CANCER | Apr 20, 2022 | Pending |
Array
(
[id] => 17928349
[patent_doc_number] => 20220323474
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => DRUG COMBINATION TREATMENTS USING BONE-TARGETING THERAPEUTICS FOR BONE AND BONE-RELATED DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/725237
[patent_app_country] => US
[patent_app_date] => 2022-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5691
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17725237
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/725237 | DRUG COMBINATION TREATMENTS USING BONE-TARGETING THERAPEUTICS FOR BONE AND BONE-RELATED DISEASE | Apr 19, 2022 | Abandoned |
Array
(
[id] => 20302395
[patent_doc_number] => 12448373
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-21
[patent_title] => Azetidinyl-acetamides as CXCR7 inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/722491
[patent_app_country] => US
[patent_app_date] => 2022-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20892
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 377
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17722491
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/722491 | Azetidinyl-acetamides as CXCR7 inhibitors | Apr 17, 2022 | Issued |
Array
(
[id] => 17719160
[patent_doc_number] => 20220211879
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-07
[patent_title] => SOLVENT FREE GADOLINIUM CONTRAST AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/701021
[patent_app_country] => US
[patent_app_date] => 2022-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8872
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17701021
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/701021 | SOLVENT FREE GADOLINIUM CONTRAST AGENTS | Mar 21, 2022 | Abandoned |